Clinicopathological significance of nuclear factor-κB activation in hepatocellular carcinoma

Hideki Yokoo, Jun Yasuda, Kazuaki Nakanishi, Makoto Chuma, Toshiya Kamiyama, Satoru Todo, Setsuo Hirohashi, Michiie Sakamoto

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Aim: Nuclear factor-κB (NF-κB) is a critical signaling mediator in inflammation, apoptosis resistance and oncogenesis. It has been reported that NF-κB is activated in several cancers, including hepatocellular carcinoma (HCC). Studies of genetic disruptions in mice also suggest that NF-κB plays critical roles in hepatocarcinogenesis. The aim of the present study is to characterize NF-κB activation and correlate it with the degree of malignancy in HCC. Methods: To examine the correlation between the positivity of the nuclear p50 subunit and HCC recurrence, we analyzed immunostaining of the NF-κB p50 subunit in two groups of HCC samples with known prognosis and Akt phosphorylation status: 49 patients showing early recurrence within 6months (group A) and 50 patients who were recurrence-free for at least for 3years (group B). Results: In group A, positive nuclear staining of p50 was shown in 18 cases (36.7%), whereas only one case (2.0%) in group B had positive nuclear staining of p50 (P=2.48839×10-5). This suggests a positive relationship between nuclear p50 and early recurrence and advanced HCC in humans. The presence of phosphorylated Akt correlated with nuclear staining of p50 in HCCs in group A (R2=0.213, P<0.001). Conclusion: Our results indicate that nuclear staining of p50 was clearly associated with early recurrent HCC, and the Akt pathway might play a role in NF-κB activation in a subset of early recurrent HCC.

Original languageEnglish
Pages (from-to)240-249
Number of pages10
JournalHepatology Research
Volume41
Issue number3
DOIs
Publication statusPublished - 2011 Mar

Fingerprint

Hepatocellular Carcinoma
Staining and Labeling
Recurrence
Inflammation Mediators
Neoplasms
Carcinogenesis
Phosphorylation
Apoptosis

Keywords

  • Clinical significance
  • Hepatocellular carcinoma
  • Immunohistochemistry
  • Nuclear factor-κB
  • Phosphorylated Akt

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases

Cite this

Clinicopathological significance of nuclear factor-κB activation in hepatocellular carcinoma. / Yokoo, Hideki; Yasuda, Jun; Nakanishi, Kazuaki; Chuma, Makoto; Kamiyama, Toshiya; Todo, Satoru; Hirohashi, Setsuo; Sakamoto, Michiie.

In: Hepatology Research, Vol. 41, No. 3, 03.2011, p. 240-249.

Research output: Contribution to journalArticle

Yokoo, H, Yasuda, J, Nakanishi, K, Chuma, M, Kamiyama, T, Todo, S, Hirohashi, S & Sakamoto, M 2011, 'Clinicopathological significance of nuclear factor-κB activation in hepatocellular carcinoma', Hepatology Research, vol. 41, no. 3, pp. 240-249. https://doi.org/10.1111/j.1872-034X.2010.00758.x
Yokoo, Hideki ; Yasuda, Jun ; Nakanishi, Kazuaki ; Chuma, Makoto ; Kamiyama, Toshiya ; Todo, Satoru ; Hirohashi, Setsuo ; Sakamoto, Michiie. / Clinicopathological significance of nuclear factor-κB activation in hepatocellular carcinoma. In: Hepatology Research. 2011 ; Vol. 41, No. 3. pp. 240-249.
@article{f3c94b5d007046d68b84c2f94bf11099,
title = "Clinicopathological significance of nuclear factor-κB activation in hepatocellular carcinoma",
abstract = "Aim: Nuclear factor-κB (NF-κB) is a critical signaling mediator in inflammation, apoptosis resistance and oncogenesis. It has been reported that NF-κB is activated in several cancers, including hepatocellular carcinoma (HCC). Studies of genetic disruptions in mice also suggest that NF-κB plays critical roles in hepatocarcinogenesis. The aim of the present study is to characterize NF-κB activation and correlate it with the degree of malignancy in HCC. Methods: To examine the correlation between the positivity of the nuclear p50 subunit and HCC recurrence, we analyzed immunostaining of the NF-κB p50 subunit in two groups of HCC samples with known prognosis and Akt phosphorylation status: 49 patients showing early recurrence within 6months (group A) and 50 patients who were recurrence-free for at least for 3years (group B). Results: In group A, positive nuclear staining of p50 was shown in 18 cases (36.7{\%}), whereas only one case (2.0{\%}) in group B had positive nuclear staining of p50 (P=2.48839×10-5). This suggests a positive relationship between nuclear p50 and early recurrence and advanced HCC in humans. The presence of phosphorylated Akt correlated with nuclear staining of p50 in HCCs in group A (R2=0.213, P<0.001). Conclusion: Our results indicate that nuclear staining of p50 was clearly associated with early recurrent HCC, and the Akt pathway might play a role in NF-κB activation in a subset of early recurrent HCC.",
keywords = "Clinical significance, Hepatocellular carcinoma, Immunohistochemistry, Nuclear factor-κB, Phosphorylated Akt",
author = "Hideki Yokoo and Jun Yasuda and Kazuaki Nakanishi and Makoto Chuma and Toshiya Kamiyama and Satoru Todo and Setsuo Hirohashi and Michiie Sakamoto",
year = "2011",
month = "3",
doi = "10.1111/j.1872-034X.2010.00758.x",
language = "English",
volume = "41",
pages = "240--249",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "3",

}

TY - JOUR

T1 - Clinicopathological significance of nuclear factor-κB activation in hepatocellular carcinoma

AU - Yokoo, Hideki

AU - Yasuda, Jun

AU - Nakanishi, Kazuaki

AU - Chuma, Makoto

AU - Kamiyama, Toshiya

AU - Todo, Satoru

AU - Hirohashi, Setsuo

AU - Sakamoto, Michiie

PY - 2011/3

Y1 - 2011/3

N2 - Aim: Nuclear factor-κB (NF-κB) is a critical signaling mediator in inflammation, apoptosis resistance and oncogenesis. It has been reported that NF-κB is activated in several cancers, including hepatocellular carcinoma (HCC). Studies of genetic disruptions in mice also suggest that NF-κB plays critical roles in hepatocarcinogenesis. The aim of the present study is to characterize NF-κB activation and correlate it with the degree of malignancy in HCC. Methods: To examine the correlation between the positivity of the nuclear p50 subunit and HCC recurrence, we analyzed immunostaining of the NF-κB p50 subunit in two groups of HCC samples with known prognosis and Akt phosphorylation status: 49 patients showing early recurrence within 6months (group A) and 50 patients who were recurrence-free for at least for 3years (group B). Results: In group A, positive nuclear staining of p50 was shown in 18 cases (36.7%), whereas only one case (2.0%) in group B had positive nuclear staining of p50 (P=2.48839×10-5). This suggests a positive relationship between nuclear p50 and early recurrence and advanced HCC in humans. The presence of phosphorylated Akt correlated with nuclear staining of p50 in HCCs in group A (R2=0.213, P<0.001). Conclusion: Our results indicate that nuclear staining of p50 was clearly associated with early recurrent HCC, and the Akt pathway might play a role in NF-κB activation in a subset of early recurrent HCC.

AB - Aim: Nuclear factor-κB (NF-κB) is a critical signaling mediator in inflammation, apoptosis resistance and oncogenesis. It has been reported that NF-κB is activated in several cancers, including hepatocellular carcinoma (HCC). Studies of genetic disruptions in mice also suggest that NF-κB plays critical roles in hepatocarcinogenesis. The aim of the present study is to characterize NF-κB activation and correlate it with the degree of malignancy in HCC. Methods: To examine the correlation between the positivity of the nuclear p50 subunit and HCC recurrence, we analyzed immunostaining of the NF-κB p50 subunit in two groups of HCC samples with known prognosis and Akt phosphorylation status: 49 patients showing early recurrence within 6months (group A) and 50 patients who were recurrence-free for at least for 3years (group B). Results: In group A, positive nuclear staining of p50 was shown in 18 cases (36.7%), whereas only one case (2.0%) in group B had positive nuclear staining of p50 (P=2.48839×10-5). This suggests a positive relationship between nuclear p50 and early recurrence and advanced HCC in humans. The presence of phosphorylated Akt correlated with nuclear staining of p50 in HCCs in group A (R2=0.213, P<0.001). Conclusion: Our results indicate that nuclear staining of p50 was clearly associated with early recurrent HCC, and the Akt pathway might play a role in NF-κB activation in a subset of early recurrent HCC.

KW - Clinical significance

KW - Hepatocellular carcinoma

KW - Immunohistochemistry

KW - Nuclear factor-κB

KW - Phosphorylated Akt

UR - http://www.scopus.com/inward/record.url?scp=79951790071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951790071&partnerID=8YFLogxK

U2 - 10.1111/j.1872-034X.2010.00758.x

DO - 10.1111/j.1872-034X.2010.00758.x

M3 - Article

VL - 41

SP - 240

EP - 249

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 3

ER -